Skip to content
healthcare.dev

DARUNAVIR

NDC 68180-346, DARUNAVIR, tablet, film coated, from Lupin Pharmaceuticals, Inc..

Product NDC
68180-346
Status
Listed
Labeler
Lupin Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202073
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68180-346 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DARUNAVIR ETHANOLATE800 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; HIV Protease Inhibitors [MoA]; Protease Inhibitor [EPC]

Package NDCNDC-11Package
68180-346-066818003460630 TABLET, FILM COATED in 1 BOTTLE (68180-346-06)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/56daf67e-7501-4cd5-be22-566d7997d42e
  • NADAC price for package 68180034606

    GET /v1/drugs/nadac/68180034606

Use it

Look up 68180-346 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68180-346 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68180-346. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.